| Primary |
| Asthma |
54.0% |
| Chronic Obstructive Pulmonary Disease |
10.7% |
| Product Used For Unknown Indication |
7.2% |
| Dyspnoea |
6.1% |
| Hypersensitivity |
3.0% |
| Bronchitis |
2.8% |
| Emphysema |
2.8% |
| Wheezing |
2.8% |
| Drug Use For Unknown Indication |
2.3% |
| Cough |
1.9% |
| Bronchospasm |
1.2% |
| Bronchitis Chronic |
0.9% |
| Lung Disorder |
0.9% |
| Pneumonia |
0.7% |
| Asthma Exercise Induced |
0.5% |
| Obstructive Airways Disorder |
0.5% |
| Respiratory Disorder |
0.5% |
| Seasonal Allergy |
0.5% |
| Upper Respiratory Tract Infection |
0.5% |
| Alpha-1 Anti-trypsin Deficiency |
0.2% |
|
| Product Quality Issue |
63.1% |
| Underdose |
7.5% |
| Wheezing |
5.1% |
| Drug Ineffective |
3.3% |
| No Adverse Event |
3.3% |
| Dyspnoea |
2.4% |
| Pharmaceutical Product Complaint |
2.4% |
| Product Container Issue |
1.7% |
| Drug Dose Omission |
1.6% |
| Product Packaging Quantity Issue |
1.4% |
| Therapeutic Product Ineffective |
1.4% |
| Product Packaging Issue |
0.9% |
| Product Taste Abnormal |
0.9% |
| Throat Irritation |
0.9% |
| Asthma |
0.7% |
| Death |
0.7% |
| Fall |
0.7% |
| Malaise |
0.7% |
| No Therapeutic Response |
0.7% |
| Palpitations |
0.7% |
|
| Secondary |
| Asthma |
33.7% |
| Chronic Obstructive Pulmonary Disease |
18.9% |
| Drug Use For Unknown Indication |
11.3% |
| Product Used For Unknown Indication |
7.8% |
| Bronchitis |
3.8% |
| Dyspnoea |
3.5% |
| Emphysema |
3.5% |
| Wheezing |
3.5% |
| Hypersensitivity |
2.3% |
| Cough |
1.7% |
| Sinus Congestion |
1.7% |
| Bronchitis Chronic |
1.5% |
| Depression |
1.2% |
| Drug Dependence |
1.2% |
| Sinusitis |
1.2% |
| Multiple Allergies |
0.9% |
| Anxiety |
0.6% |
| Asthma Exercise Induced |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Bronchiolitis |
0.6% |
|
| Product Quality Issue |
35.7% |
| Product Packaging Quantity Issue |
14.0% |
| Wheezing |
10.9% |
| Drug Ineffective |
6.2% |
| Dyspnoea |
5.4% |
| Death |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Underdose |
3.1% |
| Pyrexia |
2.3% |
| Tremor |
2.3% |
| Weight Increased |
2.3% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| No Adverse Event |
1.6% |
| Palpitations |
1.6% |
| Product Container Issue |
1.6% |
| Pruritus |
1.6% |
| Throat Irritation |
1.6% |
| Aortic Valve Incompetence |
0.8% |
| Asthma |
0.8% |
| Chest Pain |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Asthma |
18.9% |
| Drug Use For Unknown Indication |
10.3% |
| Chronic Obstructive Pulmonary Disease |
9.5% |
| Hypertension |
4.8% |
| Pain |
4.0% |
| Hypersensitivity |
3.0% |
| Depression |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Blood Cholesterol Increased |
2.2% |
| Contraception |
2.2% |
| Anxiety |
2.1% |
| Rheumatoid Arthritis |
1.9% |
| Dyspnoea |
1.8% |
| Diabetes Mellitus |
1.8% |
| Osteoporosis |
1.7% |
| Arthritis |
1.6% |
| Emphysema |
1.5% |
| Hiv Infection |
1.2% |
| Prophylaxis |
1.1% |
|
| Dyspnoea |
10.3% |
| Vomiting |
8.4% |
| Drug Ineffective |
8.2% |
| Product Quality Issue |
7.2% |
| Pain |
7.1% |
| Wheezing |
6.9% |
| Pulmonary Embolism |
6.6% |
| Weight Increased |
6.4% |
| Pneumonia |
4.4% |
| Death |
3.9% |
| Rash |
3.7% |
| Weight Decreased |
3.6% |
| Urticaria |
3.3% |
| Oedema Peripheral |
3.0% |
| Deep Vein Thrombosis |
2.9% |
| Pharmaceutical Product Complaint |
2.9% |
| Urinary Tract Infection |
2.9% |
| Asthma |
2.8% |
| Throat Tightness |
2.8% |
| Visual Impairment |
2.7% |
|
